Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Tuberculosis Prevention and Treatment Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tuberculosis Prevention and Treatment Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tuberculosis Prevention and Treatment Vaccine Overall Market Size
2.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size: 2021 VS 2028
2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Tuberculosis Prevention and Treatment Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Tuberculosis Prevention and Treatment Vaccine Players in Global Market
3.2 Top Global Tuberculosis Prevention and Treatment Vaccine Companies Ranked by Revenue
3.3 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Companies
3.4 Global Tuberculosis Prevention and Treatment Vaccine Sales by Companies
3.5 Global Tuberculosis Prevention and Treatment Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Tuberculosis Prevention and Treatment Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Tuberculosis Prevention and Treatment Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tuberculosis Prevention and Treatment Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Tuberculosis Prevention and Treatment Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Tuberculosis Prevention and Treatment Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tuberculosis Prevention and Treatment Vaccine Market Size Markets, 2021 & 2028
4.1.2 Immune Vaccine
4.1.3 Therapy Vaccine
4.2 By Type - Global Tuberculosis Prevention and Treatment Vaccine Revenue & Forecasts
4.2.1 By Type - Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Tuberculosis Prevention and Treatment Vaccine Sales & Forecasts
4.3.1 By Type - Global Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2022
4.3.2 By Type - Global Tuberculosis Prevention and Treatment Vaccine Sales, 2023-2028
4.3.3 By Type - Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Tuberculosis Prevention and Treatment Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Tuberculosis Prevention and Treatment Vaccine Market Size, 2021 & 2028
5.1.2 Self-Procurement
5.1.3 UNICEF
5.1.4 Other
5.2 By Application - Global Tuberculosis Prevention and Treatment Vaccine Revenue & Forecasts
5.2.1 By Application - Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Tuberculosis Prevention and Treatment Vaccine Sales & Forecasts
5.3.1 By Application - Global Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2022
5.3.2 By Application - Global Tuberculosis Prevention and Treatment Vaccine Sales, 2023-2028
5.3.3 By Application - Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Tuberculosis Prevention and Treatment Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Tuberculosis Prevention and Treatment Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Tuberculosis Prevention and Treatment Vaccine Revenue & Forecasts
6.2.1 By Region - Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Tuberculosis Prevention and Treatment Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Tuberculosis Prevention and Treatment Vaccine Sales & Forecasts
6.3.1 By Region - Global Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2022
6.3.2 By Region - Global Tuberculosis Prevention and Treatment Vaccine Sales, 2023-2028
6.3.3 By Region - Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2028
6.4.3 US Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.4.4 Canada Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.4.5 Mexico Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2028
6.5.3 Germany Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5.4 France Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5.5 U.K. Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5.6 Italy Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5.7 Russia Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.5.9 Benelux Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2028
6.6.3 China Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.6.4 Japan Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.6.5 South Korea Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.6.7 India Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2028
6.7.3 Brazil Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.7.4 Argentina Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales, 2017-2028
6.8.3 Turkey Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.8.4 Israel Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
6.8.6 UAE Tuberculosis Prevention and Treatment Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.1.4 Merck Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Corporate Summary
7.2.2 Japan BCG Lab Business Overview
7.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.2.4 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Japan BCG Lab Key News
7.3 Serum Institute of India
7.3.1 Serum Institute of India Corporate Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.3.4 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Serum Institute of India Key News
7.4 AJ Vaccines
7.4.1 AJ Vaccines Corporate Summary
7.4.2 AJ Vaccines Business Overview
7.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.4.4 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 AJ Vaccines Key News
7.5 BioFarma
7.5.1 BioFarma Corporate Summary
7.5.2 BioFarma Business Overview
7.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.5.4 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 BioFarma Key News
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Corporate Summary
7.6.2 GreenSignal Bio Pharma Business Overview
7.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.6.4 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 GreenSignal Bio Pharma Key News
7.7 China National Biotec
7.7.1 China National Biotec Corporate Summary
7.7.2 China National Biotec Business Overview
7.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.7.4 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 China National Biotec Key News
7.8 Biomed Lublin
7.8.1 Biomed Lublin Corporate Summary
7.8.2 Biomed Lublin Business Overview
7.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.8.4 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Biomed Lublin Key News
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Corporate Summary
7.9.2 Taj Pharmaceuticals Business Overview
7.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.9.4 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Taj Pharmaceuticals Key News
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Corporate Summary
7.10.2 Ataulpho de Paiva Business Overview
7.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.10.4 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Ataulpho de Paiva Key News
7.11 IVAC
7.11.1 IVAC Corporate Summary
7.11.2 IVAC Tuberculosis Prevention and Treatment Vaccine Business Overview
7.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.11.4 IVAC Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 IVAC Key News
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Corporate Summary
7.12.2 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Business Overview
7.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.12.4 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Queen Saovabha Mem. Inst Key News
7.13 Microgen
7.13.1 Microgen Corporate Summary
7.13.2 Microgen Tuberculosis Prevention and Treatment Vaccine Business Overview
7.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Major Product Offerings
7.13.4 Microgen Tuberculosis Prevention and Treatment Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Microgen Key News
8 Global Tuberculosis Prevention and Treatment Vaccine Production Capacity, Analysis
8.1 Global Tuberculosis Prevention and Treatment Vaccine Production Capacity, 2017-2028
8.2 Tuberculosis Prevention and Treatment Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Tuberculosis Prevention and Treatment Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tuberculosis Prevention and Treatment Vaccine Supply Chain Analysis
10.1 Tuberculosis Prevention and Treatment Vaccine Industry Value Chain
10.2 Tuberculosis Prevention and Treatment Vaccine Upstream Market
10.3 Tuberculosis Prevention and Treatment Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tuberculosis Prevention and Treatment Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer